(Q40146301)

17 September 2017

1 reference

title

Calcium antagonists. Pharmacokinetic properties (English)

1 reference

17 September 2017

Calcium Antagonists Pharmacokinetic Properties (English)

1 reference

10.2165/00003495-198325020-00002

Crossref

DOI

https://api.crossref.org/works/10.2165/00003495-198325020-00002

2 October 2023

1 reference

R. E. Kates

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6339196

2 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6339196

2 October 2023

publication date

1 February 1983

1 reference

17 September 2017

1 reference

17 September 2017

volume

25

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

113-124

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198325020-00002

17 September 2017

exact match

0 references

cites work

Pharmacokinetics and metabolism of diltiazem in man

1 reference

12 December 2020

Analysis of verapamil in plasma by liquid chromatography

1 reference

12 December 2020

The Pharmacology of Verapamil. III. Pharmacokinetics in Normal Subjects After Intravenous Drug Administration

1 reference

12 December 2020

Simultaneous determination of verapamil and its seven metabolites by high-performance liquid chromatography

1 reference

12 December 2020

Physiological disposition of verapamil in man

1 reference

12 December 2020

Verapamil kinetics in normal subjects and patients with coronary artery spasm

1 reference

12 December 2020

GLC Assay of Verapamil in Plasma: Identification of Fluorescent Metabolites after Oral Drug Administration

1 reference

12 December 2020

Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation

1 reference

12 December 2020

Variability in heparin effect on serum drug binding.

1 reference

12 December 2020

Fluorometric Assay of Verapamil in Biological Fluids and Tissues

1 reference

12 December 2020

Verapamil disposition kinetics in chronic atrial fibrillation

1 reference

12 December 2020

Determination of verapamil in human plasma by mass fragmentography using stable isotope-labelled verapamil as internal standard

1 reference

12 December 2020

Pharmacokinetics of verapamil in man

1 reference

12 December 2020

Influence of meso-caval shunt surgery on verapamil kinetics, bioavailability and response

1 reference

12 December 2020

High-performance liquid chromatographic analysis of verapamil. II. Simultaneous quantitation of verapamil and its active metabolite, norverapamil

1 reference

12 December 2020

Structural analysis of the renal excretion products of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester

1 reference

12 December 2020

Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil.

1 reference

12 December 2020

Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog.

1 reference

12 December 2020

The long-term effect of verapamil on plasma digoxin concentration and renal digoxin clearance in healthy subjects

1 reference

12 December 2020

Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single i.v. and oral administration and during chronic treatment

1 reference

12 December 2020

Improvement of the quantitative determination of verapamil in human plasma

1 reference

12 December 2020

Simple sensitive and specific gas chromatographic method for the quantification of diltiazem human body fluids

1 reference

12 December 2020

Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis

1 reference

12 December 2020

Gas chromatographic determination of nifedipine and one of its metabolites using electron capture detection

1 reference

12 December 2020

Verapamil protein binding in patients and in normal subjects

1 reference

12 December 2020

Verapamil and norverapamil plasma concentrations during long-term therapy in patients with hypertrophic obstructive cardiomyopathy

1 reference

12 December 2020

The metabolism of DL-[14C]verapamil in man

1 reference

12 December 2020

The influence of verapamil on serum digoxin concentration

1 reference

12 December 2020

Gas chromatographic determination of verapamil in plasma and urine

1 reference

12 December 2020

Factors affecting the plasma protein binding of verapamil and norverapamil in man

1 reference

12 December 2020

Quantitative determination of nifedipine in human plasma by selected ion monitoring

1 reference

12 December 2020

Reduced verapamil clearance during long-term oral administration

1 reference

12 December 2020

The pharmacokinetics and pharmacology of oral diltiazem in normal volunteers

1 reference

12 December 2020

10.2165/00003495-198325020-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

17 September 2017

1032463348

0 references

1 reference